You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK):受託人完成2024年H股獎勵信託計劃授予條件下10億港元H股購買

格隆匯9月24日丨藥明康德(02359.HK)公吿,截至2024年9月24日,計劃受託人根據公司指示通過市場內交易方式實施2024年H股獎勵信託計劃項下的H股購買,累計使用資金10億港元,購買H股股份數為27,478,428H股,佔公司截至本公吿日期已發行股本總額的約0.94%,前述購買H股股份數將作為2024年H股獎勵信託計劃項下基本授予條件(即集團於2024年實現的營業收入達到人民幣383億元或以上)達成後向選定參與者授予獎勵的股份來源。

為便於投資者瞭解2024年H股獎勵信託計劃的實施進展作出如上説明,儘管如此,2024年H股獎勵信託計劃的基本授予條件能否達成存在不確定性,公司將根據適用法律法規及2024年H股獎勵信託計劃的規定執行相關計劃。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account